Page last updated: 2024-10-31

mirtazapine and Malignant Melanoma

mirtazapine has been researched along with Malignant Melanoma in 2 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puzik, A1
Möller, J1
Meiss, F1
Kontny, U1
Rössler, J1
Uzawa, K1
Kasamatsu, A1
Shimizu, T1
Saito, Y1
Baba, T1
Sakuma, K1
Fushimi, K1
Sakamoto, Y1
Ogawara, K1
Shiiba, M1
Tanzawa, H1

Other Studies

2 other studies available for mirtazapine and Malignant Melanoma

ArticleYear
Side effects of interferon therapy in adolescent melanoma.
    Pediatric hematology and oncology, 2014, Volume: 31, Issue:4

    Topics: Adolescent; Adrenergic alpha-Antagonists; Depression; Humans; Immunologic Factors; Interferon-alpha;

2014
Suppression of metastasis by mirtazapine via restoration of the Lin-7C/β-catenin pathway in human cancer cells.
    Scientific reports, 2014, Jun-25, Volume: 4

    Topics: Adrenergic alpha-Antagonists; Animals; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cel

2014